Fea Plus500 mg+65 mg

Fea Plus 500 mg+65 mg is a dual-action combination analgesic and antipyretic used to relieve a wide range of pain conditions and fever. The addition of caffeine to paracetamol enhances the overall analgesic efficacy, making this combination more effective than paracetamol alone for certain pain types. It is indicated for the following conditions:

• Headache — including tension-type headaches caused by stress, fatigue, or muscle tightness
• Migraine — caffeine helps by constricting dilated cerebral blood vessels, providing faster and more effective relief
• Toothache — temporary relief from mild to moderate dental pain
• Neuralgia — pain arising from nerve irritation or nerve damage
• Feverishness — reduction of elevated body temperature associated with infections or illness
• Period pain (Dysmenorrhoea) — relief from menstrual cramps and lower abdominal pain
• Sore throat — symptomatic relief from throat pain and discomfort
• Backache — relief from mild to moderate lower or upper back pain
• Aches and pains of colds and flu — including body aches, muscle soreness, and associated fever

This combination is particularly beneficial when faster onset of pain relief is desired or when standard paracetamol alone has not provided adequate relief. Always use as directed by a registered physician or pharmacist.

Fea Plus 500 mg+65 mg is a fixed-dose combination that leverages the complementary mechanisms of two pharmacologically distinct agents to deliver enhanced analgesic and antipyretic effects.

Paracetamol (Acetaminophen)

Paracetamol is a centrally and peripherally acting non-opioid analgesic with well-established antipyretic properties and weak anti-inflammatory activity. It works primarily by inhibiting the synthesis of prostaglandins in the central nervous system and by blocking pain impulse generation peripherally. It acts on the hypothalamic heat-regulating center to reduce fever by promoting heat dissipation through vasodilation and sweating. Unlike NSAIDs, paracetamol does not significantly inhibit peripheral cyclooxygenase enzymes, which accounts for its lack of anti-inflammatory potency and its favourable gastric tolerability profile.

Caffeine

Caffeine is a methylxanthine alkaloid — structurally related to theophylline — that acts as a central nervous system stimulant and adjuvant analgesic. When combined with paracetamol, caffeine contributes to enhanced pain relief through several mechanisms:

• Solubility and absorption enhancement: Through intermolecular association, caffeine increases the aqueous solubility of paracetamol, facilitating faster gastrointestinal absorption and improved transmembrane permeation. This leads to a quicker onset of analgesic action.
• Pain threshold elevation: Caffeine raises the pain threshold, meaning a greater stimulus is required to produce the sensation of pain. It also increases pain tolerance, allowing patients to better cope with existing discomfort.
• Cerebrovascular vasoconstriction: Caffeine has intrinsic vasoconstrictive properties in cerebral blood vessels. Since migraine and certain headaches involve vasodilation of intracranial vessels, caffeine-mediated vasoconstriction provides targeted relief — a mechanism not available with paracetamol alone.
• Adenosine receptor antagonism: Caffeine blocks adenosine receptors in the brain, reducing the sedative and pain-sensitizing effects of adenosine, thereby contributing to an improved sense of alertness and pain control.

Together, these synergistic actions make the Fea Plus 500 mg+65 mg combination significantly more effective than either agent used alone for the management of headache, migraine, and other pain states.

Fea Plus 500 mg+65 mg may interact with a number of drugs. Always inform your doctor or pharmacist about all prescription medicines, over-the-counter drugs, and herbal supplements you are currently taking before starting this combination. Key interactions include:

Interactions Reducing Paracetamol Efficacy

• Anticonvulsants (Phenytoin, Phenobarbitone, Carbamazepine): These enzyme-inducing agents accelerate the hepatic metabolism of paracetamol, significantly reducing its plasma concentration and analgesic effectiveness. Patients on anticonvulsant therapy may require dose adjustments or alternative analgesics.
• Colestyramine (Cholestyramine): When taken within 1 hour of paracetamol administration, colestyramine can bind to paracetamol in the gastrointestinal tract and reduce its absorption. To avoid this interaction, paracetamol should be taken at least 1 hour before or several hours after colestyramine.

Interactions Increasing Risk of Adverse Effects

• Warfarin and other coumarin anticoagulants: Prolonged or regular use of paracetamol (more than a few days) may enhance the anticoagulant effect of warfarin, increasing the risk of bleeding. INR should be monitored closely in patients on anticoagulant therapy who require regular paracetamol use.
• Probenecid: This gout medication inhibits the renal excretion and hepatic conjugation of paracetamol, leading to elevated serum paracetamol levels. A reduction in the paracetamol dose may be necessary when used concurrently.
• Chloramphenicol: Paracetamol may inhibit the metabolism of chloramphenicol, resulting in increased serum levels of chloramphenicol and a higher risk of chloramphenicol toxicity.
• Phenothiazines (e.g., Chlorpromazine): Concurrent use of paracetamol with phenothiazines may cause severe hypothermia (dangerously low body temperature). This combination should be used with extreme caution or avoided.

Interactions Affecting Absorption Rate

• Metoclopramide and Domperidone: These prokinetic agents accelerate gastric emptying, thereby increasing the rate of paracetamol absorption from the small intestine. This can result in a faster onset of analgesia but does not significantly alter the total amount absorbed.

Alcohol

Consuming alcohol regularly or in large amounts while taking paracetamol significantly increases the risk of hepatotoxicity (liver damage). Patients who drink alcohol regularly should consult a physician before using paracetamol-containing products.

When used at recommended doses, Fea Plus 500 mg+65 mg is generally well tolerated. Most people experience no side effects. However, adverse reactions can occur and may be related to either the paracetamol or caffeine component.

Paracetamol-Related Side Effects

Side effects attributable to paracetamol are generally mild and uncommon at therapeutic doses. However, the following have been reported:

• Haematological reactions (rare): Thrombocytopenia (low platelet count), leukopenia (low white blood cell count), pancytopenia (reduction in all blood cell types), neutropenia, and agranulocytosis have been reported in rare cases, particularly with prolonged use.
• Hepatotoxicity: Liver damage is the most serious risk associated with paracetamol — typically occurring only with overdose or chronic excessive use, especially in patients with liver disease or those who consume alcohol regularly.
• Pancreatitis: Inflammation of the pancreas has been reported occasionally with paracetamol use.
• Skin and allergic reactions: Skin rashes, urticaria (hives), and other hypersensitivity reactions occur occasionally. Serious skin reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) have been reported very rarely; discontinue use immediately if a skin reaction develops.
• Gastrointestinal effects: Nausea, vomiting, and abdominal discomfort may occur, particularly at higher doses.

Caffeine-Related Side Effects

• Central nervous system: Restlessness, insomnia, anxiety, irritability, and headache (especially upon abrupt discontinuation after regular use)
• Cardiovascular: Palpitations, tachycardia (rapid heartbeat), and mild blood pressure elevation may occur, particularly in caffeine-sensitive individuals
• Gastrointestinal: Nausea, stomach upset, or increased gastric acid secretion
• Dependence: Regular use of caffeine-containing products can lead to mild physical dependence; abrupt discontinuation may cause withdrawal headaches

When to Seek Medical Attention

Stop taking Fea Plus 500 mg+65 mg and seek immediate medical attention if you experience any of the following:

• Yellowing of the skin or eyes (jaundice), dark urine, or severe abdominal pain — signs of liver injury
• Unusual bruising or bleeding — possible haematological reaction
• Severe skin reactions such as blistering, peeling, or widespread rash
• Signs of allergic reaction: difficulty breathing, swelling of the face, lips, or throat

Use During Pregnancy

Paracetamol has been widely used during pregnancy for decades and is generally considered the analgesic and antipyretic of choice for pregnant women when used at the lowest effective dose for the shortest necessary duration. However, emerging research suggests that prolonged or high-dose exposure may be associated with potential developmental effects on the foetus. Pregnant women should always consult their doctor or midwife before taking Fea Plus 500 mg+65 mg.

The caffeine component is of particular concern during pregnancy. Caffeine crosses the placenta, and the foetus has limited ability to metabolize it. High caffeine intake during pregnancy has been associated with an increased risk of low birth weight and pregnancy complications. Most health guidelines recommend limiting total caffeine intake to less than 200 mg per day during pregnancy from all sources (food, drinks, and medicines combined).

Use of this combination during the first trimester and late stages of pregnancy should be under direct medical supervision only.

Use During Breastfeeding (Lactation)

Paracetamol is considered compatible with breastfeeding. It is excreted into breast milk only in small amounts and is unlikely to affect the nursing infant when used at recommended therapeutic doses.

Caffeine is also excreted into breast milk and may cause irritability or sleep disturbances in some breastfed infants, particularly newborns. Breastfeeding mothers should be mindful of their total daily caffeine intake from all sources. Occasional short-term use of Fea Plus 500 mg+65 mg while breastfeeding is generally considered acceptable, but regular use should be discussed with a healthcare provider.

Before using Fea Plus 500 mg+65 mg, patients and healthcare providers should carefully consider the following precautions:

Hepatic (Liver) Conditions

Use with particular caution in patients with any degree of hepatic impairment, hepatic fibrosis, alcoholic liver disease, or Gilbert's syndrome. Paracetamol is predominantly metabolized in the liver, and even mild hepatic dysfunction can impair its safe elimination. The maximum daily dose may need to be reduced in these patients.

Renal (Kidney) Conditions

Patients with renal failure or significantly reduced kidney function should use this combination cautiously. Paracetamol metabolites are renally excreted, and impaired elimination can increase the risk of toxicity. Dose intervals should be extended as advised by a physician.

Concurrent Hepatotoxic Medications

Fea Plus 500 mg+65 mg should be used with caution in patients already taking other hepatotoxic (liver-damaging) drugs, including anti-tuberculosis medications (e.g., isoniazid), statins, or anticonvulsants that induce liver enzymes. The combined hepatic burden may increase the risk of liver damage.

Alcohol Consumption

Patients who regularly consume alcohol — particularly those who are heavy or chronic drinkers — face a significantly elevated risk of paracetamol-induced liver injury. Alcohol induces cytochrome P450 enzymes (particularly CYP2E1), which increase the production of the toxic paracetamol metabolite NAPQI, even at standard therapeutic doses. Such patients should avoid or minimize use of paracetamol-containing products.

Risk of Paracetamol Overdose from Multiple Sources

Many over-the-counter cold, flu, and pain relief products already contain paracetamol. Patients should carefully check the ingredients of all medicines they are taking simultaneously to avoid inadvertent paracetamol overdose, which can cause severe and potentially fatal liver damage.

Caffeine Sensitivity

Individuals who are sensitive to caffeine (including those with anxiety disorders, insomnia, arrhythmias, hypertension, or peptic ulcer disease) should use this combination with caution. Caffeine may worsen these conditions.

Prolonged Use

Do not use this medication continuously for extended periods without consulting a physician. Prolonged unsupervised use of paracetamol increases the risk of hepatotoxicity and renal toxicity. Regular caffeine intake can also lead to mild dependence.

Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency

Patients with G6PD deficiency should use paracetamol-containing products with caution, as haemolytic anaemia has been reported in rare cases.

Paracetamol overdose is a medical emergency. Even if the patient appears well in the early hours after ingestion, liver damage can be severe and potentially fatal. Immediate medical attention is essential. Do not wait for symptoms to appear before seeking help.

Symptoms of Paracetamol Overdose

Overdose symptoms typically evolve in distinct phases:

Phase 1 — First 24 Hours After Ingestion

Early signs may be mild or absent, which can lead to false reassurance. Symptoms include:

• Pallor (paleness of the skin)
• Nausea and vomiting
• Anorexia (loss of appetite)
• Abdominal pain or discomfort
• General malaise and fatigue

Phase 2 — 24 to 72 Hours After Ingestion

Liver injury begins to become biochemically apparent. Right upper quadrant abdominal pain, elevated liver enzymes (AST, ALT), and signs of hepatocellular damage may manifest.

Phase 3 — 72 to 96 Hours After Ingestion

Peak hepatotoxicity occurs. Liver damage typically becomes apparent 12 to 40 hours after ingestion. Serious manifestations include:

• Hepatic necrosis and liver failure
• Jaundice (yellowing of skin and eyes)
• Coagulopathy (abnormal blood clotting)
• Abnormalities of glucose metabolism (hypoglycaemia)
• Metabolic acidosis
• Acute kidney failure (in severe cases)
• Encephalopathy (in severe liver failure)
• Death (in very severe, untreated cases)

Management of Overdose

• Seek emergency medical care immediately — even if the patient feels well.
• The specific antidote for paracetamol overdose is N-acetylcysteine (NAC), which is most effective when given within 8–10 hours of ingestion.
• Gastric lavage or administration of activated charcoal may be considered if the patient presents within 1–2 hours of ingestion.
• Supportive care, including liver function monitoring and fluid management, is essential.

Caffeine Overdose Symptoms

Excessive caffeine intake may additionally cause agitation, tremor, tachycardia (rapid heartbeat), seizures, and hypertension. These symptoms are managed with supportive care.

In case of suspected overdose, contact the nearest emergency department or a Poison Control Centre immediately. Do not delay.

Proper storage of Fea Plus 500 mg+65 mg tablets is essential to maintain drug potency, stability, and safety. Follow these guidelines:

• Store in a cool and dry place, ideally at a temperature below 30°C (86°F).
• Protect from light — keep tablets in their original packaging and away from direct sunlight or bright artificial light, which can degrade the active ingredients.
• Protect from moisture — do not store in bathrooms or near sinks. Humidity can accelerate tablet deterioration.
• Keep the container tightly closed when not in use.
• Keep out of reach of children — store in a secure location, such as a locked medicine cabinet, to prevent accidental ingestion by children.
• Do not use tablets after the expiry date printed on the packaging. Expired medicines should be safely disposed of at a pharmacy or designated medicine disposal point — do not flush down the toilet or throw in household waste.
• Do not store in a refrigerator unless explicitly instructed to do so on the product label.